Spotlight on Fluvoxamine in Anxiety Disorders in Children and Adolescents

@article{Cheer2002SpotlightOF,
  title={Spotlight on Fluvoxamine in Anxiety Disorders in Children and Adolescents},
  author={S. Cheer and D. Figgitt},
  journal={CNS Drugs},
  year={2002},
  volume={16},
  pages={139-144}
}
  • S. Cheer, D. Figgitt
  • Published 2002
  • Medicine
  • CNS Drugs
  • AbstractFluvoxamine is a selective serotonin reuptake inhibitor (SSRI) which may be used for the management of anxiety disorders in children and adolescents. Absorption of fluvoxamine was similar in adolescents to that in adults, which suggests that the maximum dosage of the drug for patients aged between 12 and 17 years can be as high as 300 mg/day. However, steady-state plasma fluvoxamine concentrations were 2 to 3 times higher in children (aged between 6 and 11 years) than in adolescents… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 43 REFERENCES
    Preclinical evidence on the psychotropic profile of fluvoxamine.
    • 37